These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12658011)

  • 21. Aortic stiffness, left ventricular hypertrophy and weekly averaged blood pressure (WAB) in patients on haemodialysis.
    Moriya H; Ohtake T; Kobayashi S
    Nephrol Dial Transplant; 2007 Apr; 22(4):1198-204. PubMed ID: 17255132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Home BP for assessing haemodialysis hypertension.
    Agarwal R
    Nephrol Dial Transplant; 2007 Oct; 22(10):3089-90; author reply 3090. PubMed ID: 17636055
    [No Abstract]   [Full Text] [Related]  

  • 23. [Importance of detection of hypertensive reaction to physical loading in patients with or without left ventricular hypertrophy and arterial hypertension].
    Ivanov AP; Saĭeda EA; El'gardt IA; Sdobniakova NS
    Klin Med (Mosk); 2009; 87(7):24-6. PubMed ID: 19705786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory Arterial Stiffness Index is not a specific marker of reduced arterial compliance.
    Gavish B; Ben-Dov IZ; Bursztyn M
    Hypertension; 2007 Aug; 50(2):e18; author reply e19. PubMed ID: 17562980
    [No Abstract]   [Full Text] [Related]  

  • 25. Twenty-four-hour mean heart rate and likelihood of left ventricular hypertrophy.
    Palmieri V
    Am J Hypertens; 2006 Feb; 19(2):178. PubMed ID: 16448888
    [No Abstract]   [Full Text] [Related]  

  • 26. New techniques for assessing arterial stiffness.
    Boutouyrie P
    Diabetes Metab; 2008 Feb; 34 Suppl 1():S21-6. PubMed ID: 18358423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left-ventricular hypertrophy and coronary artery disease.
    Pierdomenico SD
    Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
    [No Abstract]   [Full Text] [Related]  

  • 28. Abnormal hemodynamic responses to exercise as a marker of end-organ damage in the "high-normal" blood pressure state.
    Grassi G
    Ital Heart J; 2005 Nov; 6(11):893-4. PubMed ID: 16320923
    [No Abstract]   [Full Text] [Related]  

  • 29. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimate of white-coat effect and arterial stiffness.
    de Simone G; Schillaci G; Chinali M; Angeli F; Reboldi GP; Verdecchia P
    J Hypertens; 2007 Apr; 25(4):827-31. PubMed ID: 17351375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial stiffness and the renin-angiotensin-aldosterone system.
    Mahmud A; Feely J
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial and cardiac changes in hypertension in the elderly.
    Asmar R; Safavian A; Tual JL; Safar ME
    Blood Press Suppl; 1995; 3():31-7. PubMed ID: 8535540
    [No Abstract]   [Full Text] [Related]  

  • 33. [Editorial comment: hypertension and ventricular arrhythmias].
    Güneri S
    Anadolu Kardiyol Derg; 2002 Dec; 2(4):300-1. PubMed ID: 12793449
    [No Abstract]   [Full Text] [Related]  

  • 34. Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping.
    Perez-Lloret S; Toblli JE; Cardinali DP; Malateste JC; Milei J
    Int J Cardiol; 2008 Jul; 127(3):387-9. PubMed ID: 17574691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood pressure components and target organ damage].
    Schillaci G; Reboldi G; Vaudo G
    Ital Heart J Suppl; 2001 Apr; 2(4):363-8. PubMed ID: 19397008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiac structure and function in patients with obstructive sleep apnea syndrome and co-prevalent arterial hypertension. Influence of CPAP therapy].
    Duchna HW; Myslinski W; Dichmann M; Rasche K; Schultze-Werninghaus G; Orth M
    Med Klin (Munich); 2006 Jan; 101(1):1-8. PubMed ID: 16418808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertrophy and ventricular remodeling in systemic arterial hypertension: role of AT1 receptors].
    Troyo Barriga P
    Arch Cardiol Mex; 2003; 73 Suppl 1():S146-9. PubMed ID: 12966667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arterial stiffness, wave reflections and myocardial protection: the REASON project].
    London GM
    Drugs; 2003; 63 Spec No 1():9-17. PubMed ID: 12708879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.